首页|Data on Prostatectomy Reported by F. Dibitetto and Colleagues (Extraperitoneal r obot assisted laparoscopic prostatectomy with Versius system: single centre expe rience)
Data on Prostatectomy Reported by F. Dibitetto and Colleagues (Extraperitoneal r obot assisted laparoscopic prostatectomy with Versius system: single centre expe rience)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Surgery-Prostatectom y is the subject of a report. According to news reporting originating from Rome, Italy, by NewsRx correspondents, research stated, "Versius Surgical System (CMR Surgical, Cambridge, UK) is a novel tele-operated robotic surgical system desig ned to assist surgeons for minimally invasive surgery which is gaining momentum in the world of robotic surgery. We describe our single centre experience with V ersius and report the advantages and challenges posed by this new robotic system in a series of 53 extraperitoneal robotic assisted laparoscopic prostatectomies (eRALP) for prostate cancer (PCa)." Our news editors obtained a quote from the research, "Data of 53 eRALP performed with Versius in our centre were collected and analysed, Descriptive statistics were used to report our results. In 16 months we performed 53 eRALP: 18 (34% ) with PLND, 33 (62%) nerve sparing cases. Mean setup time was 15 m in, mean console time was 100 min and mean operative time was 130 min. We observ ed a substantial reduction of console time and set-up time after only 5 procedur es. In the first 4 procedures, the dissection of the neurovascular bundle was pe rformed laparoscopically, to switch back to robotic assisted approach afterwards . No major system failures were observed. No major intra-operative and post-oper ative complications occurred. Mean follow-up time was 9 months (range 3-15 month s); no patients experienced biochemical recurrence or metastatic progression ove r this period, 8 (15%) patients had adjuvant radiotherapy based on unfavourable pathology report (positive surgical margins or positive limphnodes) . This represents to our knowledge the largest extraperitoneal RALP case series with Versius, and it aims to provide solid clinical proof of the safety, effecti veness and versatility of this innovative system."
NETL
NSTL
